Previous Article | Next Article ![]()
Infection and Immunity, November 2007, p. 5399-5404, Vol. 75, No. 11
0019-9567/07/$08.00+0 doi:10.1128/IAI.00663-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Kavindra V. Singh,1,2,
Sreedhar R. Nallapareddy,1,2,
and
Barbara E. Murray1,2,3*
Division of Infectious Diseases, Department of Internal Medicine,1 Center for the Study of Emerging and Reemerging Pathogens,2 Department of Microbiology and Molecular Genetics, University of Texas Medical School, Houston, Texas 770303
Received 12 May 2007/ Returned for modification 2 July 2007/ Accepted 17 August 2007
|
|
|---|
srtA
bps double mutant showed a much greater reduction (74% versus OG1RF and 44% versus the
bps mutant). In a murine urinary tract infection (UTI), the 50% infective doses of both the
srtA
bps and
bps mutants were
2 log10 greater than that of OG1RF or the
srtA mutant. Similarly,
2 log10 fewer bacteria were recovered from the kidneys after infection with the
bps mutant (P = 0.017) and the
srtA
bps double mutant (P = 0.022) compared to wild-type strain OG1RF. In a competition UTI, the
bps mutant was slightly, but not significantly, less attenuated than the
srtA
bps double mutant. Fluorescence-activated cell sorter analysis with Ebp-specific antibodies confirmed that a minority of OG1RF cells express Ebp pili on their surface in vitro and that Bps has a major role in Ebp pilus biogenesis but also indicated a function for SrtA in surface localization of the pilus subunit protein EbpA. In conclusion, deletion of bps had a major effect on virulence in murine UTIs, as well as biofilm; deletion of srtA from OG1RF had little effect on these phenotypes, but its deletion from a bps mutant had a pronounced effect on biofilm, suggesting that Bps and/or the proteins it anchors may compensate for the loss of some SrtA function(s). |
|
|---|
While analyses of sortase mutants of several gram-positive pathogens have provided evidence for their wide range of roles in bacterial physiology and pathogenesis (reviewed in reference 7), only limited information is available on the role of E. faecalis sortases. A study by Kristich et al. (5) demonstrated that SrtA anchors the plasmid-encoded protein Asc10 to the enterococcal cell wall to facilitate the pheromone-induced aggregation of E. faecalis OG1RF cells. Deletions of bee locus-linked srt-1 and srt-2 of E. faecalis E99 (23) and of the ubiquitous ebp (endocarditis and biofilm-associated pilus)-linked sortase C (encoded by bps, also referred to in earlier studies as srtC) of E. faecalis OG1RF (13) have each led to a reduction in biofilm production. It was also demonstrated that bps, but not srtA, was essential for tethering of the endocarditis-associated Ebp pili by E. faecalis OG1RF. However, what other proteins may be processed by Bps or SrtA and what role these sortases may play in virulence have not been reported.
The present study further explored the role of E. faecalis sortases by deleting independently or in combination the two sortase genes (namely, srtA and bps) present in E. faecalis strain OG1RF. Here, we generated sortase (srtA with and without bps) deletion derivatives of OG1RF and evaluated these constructs for their phenotypic effects by using biofilm assays and a mouse urinary tract infection (UTI) model and for their effect on the surface localization of Ebp pilus subunit proteins.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
Construction of sortase mutants. Nonpolar deletion mutants of E. faecalis were constructed by allelic replacement (4, 13). By crossover PCR, fragments upstream (1 kb) and downstream (900 bp) of the complete srtA open reading frame were amplified together to create a single 1.9-kb fragment with primers listed elsewhere (see Table S1 in the supplemental material). After ligating this fragment into pCJK47 (4), the construct was then transformed into Escherichia coli EC1000 (6) cells to obtain TX5497 (Table 1). After confirming the sequence, the plasmid containing the srtA up-down fragment (pTEX5497) was electroporated into E. faecalis CK111 competent cells (5). CK111 cells containing pTEX5497 were conjugated with wild-type OG1RF and TX5470 by a standard technique (12), and single-crossover integrants (OG1RF::pTEX5497 and TX5470::pTEX5497) were selected on BHIA plates which contained rifampin (100 µg/ml) with erythromycin (10 µg/ml) or spectinomycin (1,000 µg/ml). Single colonies were purified on BHIA plates with fusidic acid (25 µg/ml) with erythromycin (10 µg/ml) and subjected to the PheS* counterselection (negative selection) system with MM9YEG agar plates supplemented with 10 mM p-Cl-Phe (4) to select for double-crossover deletions. The deletions were confirmed as correct by PCR sequencing, hybridization, and pulsed-field gel electrophoresis procedures.
Growth curve experiment. Cultures of test bacteria grown overnight were diluted (1:20) in BHIS and grown at 37°C with gentle shaking. A reading of optical density at 600 nm (OD600) was taken every hour from 0 to 12 h and then at 24 h. At intervals of 0, 4, and 6 h, CFU counts were also determined by plating serial dilutions on BHIA.
Biofilm assay.
A biofilm density assay was carried out for wild-type E. faecalis OG1RF and its isogenic
srtA,
bps, and
srtA
bps deletion mutants according to a method previously described by Mohamed et al. (8).
UTI model.
Protocols for preparation of mice, inoculum volumes, and all others stages of the experiment were the same ones previously used in our laboratory (21). Initially groups of five mice per inoculum (102 to 106 CFU) were used for each test bacterial strain (wild-type OG1RF and the
srtA,
bps, and
srtA
bps mutants), resulting in several independent monoinfection experiments. In the second set of monoinfection experiments, groups of 10 additional mice were infected with an inoculum of 104 CFU. The urinary bladders and kidney pairs were excised, weighed, and homogenized in 1 ml and 5 ml of saline, respectively, and dilutions were plated onto BHIA for CFU counting. The 50% infective dose (ID50) of each test bacterium was determined by a previously described method (17). The detection limit of bacteria in this experiment was 10 CFU/ml of tissue homogenate. Identities of the test bacteria recovered from infected organs were confirmed by plating them on bile esculin azide agar plates (Difco Laboratories) and BHIA plates with rifampin (100 µg/ml) or by colony PCR. For the competition assay, cultures of
bps and
srtA
bps mutants were resuspended in saline solution and mixed in approximately equal (1:1) volumes based on OD600 readings, used to infect mice, and plated for colony counts. After 24 h, CFU were recovered from organs as previously described (21). Colony lysate preparations were probed with intragenic bps, srtA (amplified with primer sets EF3056F-EF3056R for srtA and EF1094F-EF1094R for bps), and ace (2) probes, and high-stringency hybridization techniques were used to determine the ratio of
bps mutant to
srtA
bps double mutant cells in the bacterial colonies recovered. Similar to the method previously described for E. faecalis mixed infections (13, 14), the mean virulence index of
srtA
bps mutants relative to that of
bps mutants was calculated with the following equation: Mean virulence index =
[(%
bps in inoculum)/(%
srtA
bps in inoculum)]/
[(%
bps in kidneys)/(%
srtA
bps in kidneys)].
The University of Texas Health Science Center at Houston preapproved protocol and guidelines of the Animal Welfare Committee were followed throughout the course of this study.
Polyclonal antibodies and flow cytometry. Production and purification of polyclonal antibodies against recombinant EbpA, EbpB, and EbpC proteins were described elsewhere (13). For flow cytometry analysis of surface expression of Ebp proteins, bacteria were grown in BHIS to late log phase. After being washed twice with phosphate-buffered saline (PBS), 100 µl of bacteria adjusted to an OD600 of 0.2 were suspended in 40 µl of newborn calf serum (Sigma) and incubated for 15 min at room temperature. After centrifugation at 10,000 x g for 6 min, 100 µl of 20 µg/ml preimmune or affinity-purified anti-Ebp specific antibodies in dilution buffer (PBS containing 20% newborn calf serum and 0.1% bovine serum albumin [BSA]) was added and the solution was incubated at 4°C for 2 h. The bacteria were washed twice with 400 µl of 0.1% BSA in PBS and then added to a dilution buffer containing 100 µl of 1:100-diluted goat anti-rabbit immunoglobulin G (IgG) conjugated with F(ab')2 fragment-specific R-phycoerythrin (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) and incubated at 4°C for 2 h. After cells were washed three times with 400 µl of 0.1% BSA in PBS, cells were resuspended in 500 µl of 1% paraformaldehyde in PBS and analyzed with a Coulter EPICS XL AB6064 flow cytometer (Beckman Coulter, Fullerton, CA) and System II software.
Statistics.
Differences in OD570 readings in biofilm experiments were evaluated with the Kruskal-Wallis test (analysis of variance [ANOVA]) and, in some cases, also by the Mann-Whitney test. Differences in the log10 CFU of bacteria recovered from organs in monoinfections with inocula of 104 CFU were evaluated by the unpaired t test. Differences between the total numbers of infected kidney pairs/bladder (102 to 106 CFU inoculum groups combined) were evaluated by Fisher's exact test. The percentages of the
bps mutant in the inoculum versus the percentages of the
bps mutant in the kidneys of individual mice infected with the
bps and
srtA
bps mutants in the competition assay were analyzed for significance by the paired t test.
|
|
|---|
Sortase-encoding genes of E. faecalis strains. Of the three sortase genes (srtA, EF_2524, and bps) previously identified in strain V583 (16), EF_2524 (which is part of an integrated plasmid remnant region [EF_2512 to EF_2542]) of V583 (16) was not present in seven of nine E. faecalis strains tested, including OG1RF (1, 13). Since our previous study found that bps is ubiquitous in E. faecalis (13), here we tested for the presence of srtA in 100 diverse E. faecalis strains by colony hybridization and found that this gene was also present in all of the isolates tested. The ubiquitous distribution of these two genes in diverse E. faecalis strains suggests that they are part of the core genome and have a role in E. faecalis biology. We next analyzed the almost completed genomic sequence of E. faecalis strain OG1RF (10) generated by our collaboration with the human genome sequencing center at the Baylor College of Medicine (available at http://www.hgsc.bcm.tmc.edu/projects/microbial/microbial-detail.xsp?project_id=111) and confirmed that OG1RF (which failed to hybridize with EF_2524) contains only the two ubiquitous sortase genes srtA and bps. In order to evaluate the independent roles of these sortase genes, we generated sortase (srtA and/or bps) deletion derivatives of strain OG1RF.
Deletion of E. faecalis srtA from OG1RF and from its bps deletion mutant, TX5470.
Sequencing of OG1RF
srtA (TX5536) and OG1RF
srtA
bps (TX5537) confirmed the deletion of the complete srtA open reading frame, which encodes 244 amino acids (data not shown). There were no obvious differences in the growth patterns of wild-type E. faecalis OG1RF and its isogenic sortase mutants (
srtA,
bps, and
srtA
bps), suggesting that the sortases are not essential for in vitro growth of E. faecalis.
Contribution of the srtA and bps genes to biofilm formation.
All of the sortase mutant derivatives of E. faecalis OG1RF showed decreased biofilm formation (P < 0.0001 by Kruskal-Wallis test), with reductions ranging from 5% (
srtA mutant; median OD570 = 0.893; interquartile range [IQR], 0.841 to 0.968) to 74% (
srtA
bps double mutant; median OD570 = 0.247; IQR, 0.204 to 0.274) relative to wild-type E. faecalis OG1RF (median OD570 = 0.943; IQR, 0.887 to 1.004) (Fig. 1). The decrease for the
srtA mutant was small and not significant (P > 0.05) by post-hoc test of Kruskal-Wallis ANOVA testing compared to OG1RF, although it was significant by the Mann Whitney test (Fig. 1) (P = 0.037), and observed in repeated experiments. The decrease seen with the
srtA
bps double mutant (see above) was much more substantial, with the median OD570 of
srtA
bps 44% less than that of
bps (median OD570 = 0.441; IQR, 0.396 to 0.516; P < 0.001); the results for
bps are consistent with those previously reported (13). This surprising and pronounced decrease seen with the
srtA
bps double mutant versus the
bps mutant suggests the possibilities that (i) Bps may compensate for the loss of SrtA from OG1RF and that (ii) in the absence of Bps, SrtA performs some function that is important for biofilm formation.
![]() View larger version (10K): [in a new window] |
FIG. 1. Comparison of biofilm production of wild-type OG1RF and the TX5536 ( srtA), TX5470 ( bps), and TX5537 ( srtA bps) mutants. Median values and interquartile ranges are shown. Multiple comparison of median OD570s from biofilm assays of wild-type and mutant cells by Kruskal-Wallis test (ANOVA) with Dunn's post-hoc modification showed a highly significant difference (P < 0.0001). Individual median OD570s from biofilm assays of wild-type and mutant cells were compared by Mann-Whitney test and are shown above the whiskers.
|
srtA
bps (ID50 = 1.5 x 104) and
bps (ID50 = 3.6 x 104) mutants required
2 log10 more cells to infect 50% of the mice than did wild-type E. faecalis OG1RF (ID50 = 1.1 x 102) or
srtA (ID50 = 1.4 x 102), indicating a substantial role for Bps compared to SrtA in UTI infections. Furthermore, the comparable (
2 log) difference between the ID50s of the bps mutant and that of strain OG1RF versus those of the previously reported ebp mutant and strain OG1RF (21) suggests that the effect seen after bps deletion is likely due to the resulting inability to form Ebp pili (13). For the total number of mouse kidneys and urinary bladders infected by the mutants compared to the number infected by wild-type E. faecalis OG1RF, see Table S2 in the supplemental material. The percentage of kidneys of mice infected summed across all inocula was 91% for wild-type OG1RF, 80% for the
srtA mutant (P = 0.2650), 63% for the
bps mutant (P = 0.0048), and 51% for the
srtA
bps double mutant (P < 0.0001). Although fewer bladders than kidneys were infected, the differences between individual strains were similar to those of kidney infections (see Table S2 in the supplemental material); the percentage of bladders of mice infected summed across all inocula was 78% for wild-type OG1RF, 76% for the
srtA mutant (P = 1.0), 51% for the
bps mutant (P = 0.0177), and 37% for the
srtA
bps double mutant (P = 0.0005).
The log10 CFU recovered from the kidney pairs (n = 15) of mice infected with wild-type E. faecalis OG1RF and its isogenic mutants at a 104 CFU inoculum are shown in Fig. 2. A comparison of the mean log10 CFU of bacteria recovered from the kidneys showed that the differences between OG1RF and the
bps mutant (2.1 ± 0.8 log10) and between OG1RF and the
srtA
bps double mutant (2.1 ± 0.8 log10) were statistically significant (P = 0.017 and P = 0.022, respectively), while the difference between OG1RF and the
srtA mutant (0.9 ± 0.9, P = 0.280) was not.
![]() View larger version (18K): [in a new window] |
FIG. 2. Monoinfection with wild-type E. faecalis OG1RF and its isogenic mutants. Data are from 15 mice infected with 104 CFU; results are expressed as log10 CFU per gram from kidney homogenates 48 h after transurethral challenge. The log10 CFU from both kidneys were combined and averaged. A value of 1 was assigned to those kidneys with 0 CFU. Triangles represent wild-type E. faecalis OG1RF, circles represent OG1RF srtA, diamonds represent OG1RF bps, and squares represent OG1RF srtA bps. Horizontal bars represent the geometric mean. The mean difference in CFU counts of sortase mutants versus OG1RF is given as the log10 ± the standard deviation (SD). Differences in the log10 CFU of OG1RF versus the srtA, bps, and srtA bps mutants recovered from organs were evaluated by the unpaired t test.
|
srtA
bps double mutant may be more attenuated than the
bps mutant, we next used a competition assay with an approximately equal mixture of
bps and
srtA
bps mutant cells of two different inocula. For 17 animals, the percentage of
bps mutant cells in the total inoculum was 42% to 43%. At autopsy, the percentages of
bps mutant cells in the total number of CFU recovered from kidneys were in the range of 52 to 63% for five animals and 92%, 46%, and 23% for one animal each. Nine animals were not infected. The mean percentage of
bps mutant cells in the total number of CFU of bacteria recovered from kidneys was 55.1%, demonstrating a slight outnumbering by the
bps mutant; however, the paired t test showed no significant difference between these mutants (P = 0.1097). The mean virulence index (13, 14) of the
srtA
bps double mutant relative to the
bps mutant in kidneys was 0.605, indicating that SrtA plays only a minor role in UTI or that Bps can compensate for the SrtA loss. Taken together, our bps mutant data corroborate the previously demonstrated role of Ebp pili (21) in murine kidney infections and the competition assay results suggest little to no additional role for SrtA in this model. This is in contrast to the role of SrtA in other gram-positive organisms, such as Staphylococcus aureus and Listeria monocytogenes, where SrtA plays a much larger role in virulence (7). However, it is possible that srtA of E. faecalis contributes more significantly to the UTI disease process in humans compared to mice or it may be more important for other infection processes such as endocarditis.
Role of sortases in surface localization and polymerization of Ebp pili.
By Western blotting, we have previously shown that bps, but not srtA, is needed for polymerization of Ebp pili (13) and immunogold electron microscopy estimated that few wild-type cells (<2% of cells grown in BHIB and <20% of cells grown in tryptic soy broth-0.25 M glucose) produce Ebp pili in vitro (13). Here, we measured the surface-localized Ebp proteins of wild-type OG1RF and sortase mutants after growth in BHIS (the growth condition that enhanced levels of high-molecular-weight Ebp bands in Western blot assays) (13) by fluorescence-activated cell sorting analysis. While anti-Ace antibodies (used as a positive control) bound 98% of wild-type OG1RF grown at 46°C (11) (data not shown), the percentages of EbpA-, EbpB-, and EbpC-expressing cells in BHIS cultures of strain OG1RF were 34%, 20%, and 24%, respectively (Fig. 3) and the mean fluorescence intensities of EbpA, EbpB, and EbpC were 29.8, 2.4, and 27.1, respectively. The relatively low intensity of EbpB observed in flow cytometry analysis seemed to contradict the immunoblotting data from our earlier study (13), which showed that the EbpB protein is part of the polymeric structure. One possible explanation for these results is that EbpB may be relatively hidden beneath the surface of the Ebp pilus structure and thus not accessible to antibodies in a flow cytometry analysis, as seen with group B streptococci (22). The percentages of
bps mutant cells with surface-localized EbpA, EbpB, and EbpC were 28%, 8%, and 10%, but with much lower mean fluorescence intensities (2.1, 3.0, and 2.0, respectively) (Fig. 3). This markedly reduced fluorescence intensity of Ebp proteins in the
bps mutant is consistent with the role of Bps in pilus polymerization, and this observation is consistent with loss of Ebp high-molecular-weight multimers in Western blot assays of the
bps mutant (13). Since our earlier EbpA surface localization studies by immunogold electron microscopy (13) showed staining of both the cell surface and the pili of wild-type OG1RF, the persistence of a relatively high percentage of EbpA-positive
bps mutant cells (28%), but with a greatly reduced mean fluorescence intensity (29.8 to 2.1), suggests that the EbpA subunit protein is still located on the cell surface of the bps mutant, presumably in the monomeric form. Unlike the
bps mutant, the
srtA mutant (TX5536) showed an expression pattern similar to that of wild-type OG1RF, albeit with higher mean fluorescence intensities (49.7, 3.3, and 34.3 for EbpA, EbpB, and EbpC, respectively) and some difference in the percentage of cells, with a small decrease for EbpA (34 versus 27%) and small increases for EbpB (20 versus 26%) and EbpC (24 versus 26%) (Fig. 3). These moderately increased Ebp intensities with the srtA mutant, implying enhanced pilus production compared to that of the wild type, suggest that the presence of SrtA somehow results in interference with the action of Bps for polymerization. The mutant that lacked both sortases (TX5537) showed the least surface localization (6%, 3%, and 5% of cells with mean fluorescence intensities of 1.8, 2.4, and 2.4 for EbpA, EbpB, and EbpC, respectively) (Fig. 3). The decrease in the percentage of EbpA-stained cells of the
srtA
bps double mutant (6%) compared to the
bps mutant (28%) indicates that SrtA may be involved in the surface anchoring of EbpA, at least in the absence of Bps; an additional decrease was also seen to a minor degree with both EbpB and EbpC. Taken together, these surface analysis studies indicate that both sortases are important for Ebp component surface localization in OG1RF, with Bps being the major one for pilus biogenesis, as well as for ascending murine UTI.
![]() View larger version (34K): [in a new window] |
FIG. 3. Flow cytometry analysis of surface expression of Ebp pilus proteins in wild-type E. faecalis OG1RF and its isogenic mutants. Cells were incubated with either control preimmune (PI) IgGs or anti-Ebp specific IgGs, followed by incubation with a F(ab')2 fragment of goat anti-rabbit IgGs (heavy plus light chains) conjugated to R-phycoerythrin. Bacteria were analyzed by flow cytometry by using side scatter as the threshold of detection. Specific binding by anti-Ebp antibodies is indicated as log fluorescence intensity on the x axis, and each histogram represent 50,000 bacteria.
|
This work was supported by NIH grant R37 AI 47923 from the Division of Microbiology and Infectious Diseases, NIAID, to B. E. Murray. Kelvin Kemp was supported by NIH grant T35 DK007676 from the National Institute of Diabetes and Digestive and Kidney Diseases and a Summer Scholarship Award from the Infectious Diseases Society of America.
Published ahead of print on 4 September 2007. ![]()
Supplemental material for this article may be found at http://iai.asm.org/. ![]()
K.D.K., K.V.S., and S.R.N. contributed equally to this work. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»